Integrated DNA Technologies Takes Center Stage With Presentations At ‘RNAi Europe’ & ‘Advances In QPCR’, Berlin Sept 17-18

CORALVILLE, IA – September 9 2009. Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, is attending the co-located ‘RNAi Europe’ and ‘Advances in qPCR’ conferences in Berlin, September 17-18. Dr Mark Behlke IDT’s CSO and Stephen Gunstream IDT’s qPCR and OEM Business Unit Leader, will take the stage as follows:

Dr. Mark Behlke

‘RNAi Europe’ – “Developing Dicer-Substrate siRNA Drugs.” Thurs, Sept 17 at 09:00 ‘Advances in qPCR’ – “A New Family of Nucleic-Acid Detection Assays Based Upon Thermostable RNase H2.” Fri, Sept 18 at 11:45

Stephen Gunstream

‘Advances in qPCR’ – “Simplify your qPCR Gene Expression Studies with IDT’s PrimeTime™ qPCR Assays.” Thurs, Sept 17 at 10:00

For more information on the conferences:

RNAi Europe - www.selectbiosciences.com/conferences/rnaie2009 Advances in qPCR - www.selectbiosciences.com/conferences/AqPCR2009

For more information on IDT’s products and services:

Please visit their website at www.idtdna.com

About IDT

Integrated DNA Technologies (IDT) is the largest supplier of custom nucleic acids in the United States, serving academic, government, and commercial researchers in biotechnology, clinical diagnostics, and pharmaceutical development. IDT's primary business is the manufacture of custom, synthetic DNA and RNA oligonucleotides. Today, IDT synthesizes and ships an average of 36,000 custom oligos per day to more than 86,000 customers worldwide. IDT manufacturing locations include facilities in Coralville, Iowa; San Diego, Calif.; and Leuven, Belgium. For more information visit www.idtdna.com.
MORE ON THIS TOPIC